March 26, 2024

Ron Finklestien

Dissecting the Q4 2023 Performance of Aptose Biosciences: A Deeper Look into Earnings Per Share

APTO stock - APTO Stock Earnings: Aptose Biosciences Beats EPS for Q4 2023

Source: iQoncept / Shutterstock

Aptose Biosciences (NASDAQ:APTO) reveals its latest numbers for the closing quarter of 2023.

  • Aptose Biosciences discloses earnings per share of -$1.44, a figure that surpasses the forecasted EPS of -$1.59.
  • For the quarter in question, the company registers no revenue reported.

InvestorPlace Earnings offers a meticulous breakdown using data from TradeSmith to mechanize its coverage of quarterly earnings results. By assessing critical aspects like earnings per share, revenue, and juxtaposing a company’s performance against analyst projections, InvestorPlace Earnings ensures prompt dissemination of information to our audience. These write-ups are generated autonomously, guaranteeing timely updates. Any discrepancies should be directed to [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/apto-stock-earnings-aptose-biosciences-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Latest articles



Subscribe to Pivot and Flow Daily